國立虎尾科技大學 |

High-Density Lipoproteins as Biomarkers and Therapeutic Tools = Volume 2. Improvement and Enhancement of HDL and Clinical Applications /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	High-Density Lipoproteins as Biomarkers and Therapeutic Tools/ by Kyung-Hyun Cho.
Reminder of title:	Volume 2. Improvement and Enhancement of HDL and Clinical Applications /
Author:	Cho, Kyung-Hyun.
Description:	XVI, 268 p. 174 illus.online resource. :
Contained By:	Springer Nature eBook
Subject:	Molecular biology. -
Online resource:	https://doi.org/10.1007/978-981-13-7383-1
ISBN:	9789811373831

High-Density Lipoproteins as Biomarkers and Therapeutic Tools = Volume 2. Improvement and Enhancement of HDL and Clinical Applications /
Cho, Kyung-Hyun.

High-Density Lipoproteins as Biomarkers and Therapeutic ToolsVolume 2. Improvement and Enhancement of HDL and Clinical Applications /[electronic resource] :by Kyung-Hyun Cho. - 1st ed. 2019. - XVI, 268 p. 174 illus.online resource.

Chapter 1. Improvement of HDL -- 1-1.Clinical application of HDL: Overview -- 1-2.Regression effect of V156K-apoA-I -- 1-3.Anti-diabetic effect of V156K-apoA-I -- 1-4.Vitamin C and HDL -- 1-5.Growth hormone-1 in HDL -- 1-6.Growth hormone-2 in HDL -- 1-7.Omega-3 and HDL -- Chapter 2. HDL as therapeutic tools -- 2-1.Delivery vehicle for therapeutics : Overview -- 2-2.Gene delivery: adenovirus and V156K-apoA-I -- 2-3.Solubilization of rapamycin and delivery -- 2-4.Solubilization of minoxidil and delivery -- Chapter 3. Enhancement of HDL by policosanol: anti-aging and longevity -- 3-1.Policosanol and HDL functionality -- 3-2.Policosanol and raising HDL in zebrafish -- 3-3.Policosanol and CETP inhibition: human trial 8 weeks -- 3-4.Policosanol and blood pressure lowering: human trial 8 weeks -- 3-5.Policosanol blood pressure lowering human trial for 24 weeks -- 3-6.Policosanol and improvement of aortic stiffness -- 3-7.Policosanol and blood pressure lowering in rat model -- 3-8.Twelve week consumption of policosanol and lowering blood pressure -- 3-9.Publication analysis of policosanol-related studies -- 3-10.Athero-protective effects of policosanol and sugar cane wax acid -- 3-11.Cuban sugarcane wax acids and policosanol improved serum lipid profiles -- Summary and perspectives -- Epilogue.

This book is the second of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date information is provided on such topics as the tumor regression-promoting and antidiabetic activities of reconstituted HDL containing V156K apolipoprotein A-I, the enhancement of HDL effects by high doses of vitamin C, the benefits derived from incorporation of growth hormones 1 and 2 into rHDL, and the biological functions of omega-3 linolenic acid in rHDL. The enhancement of HDL functionality by policosanol and the resultant benefits are thoroughly examined in a separate section. Readers will also find the latest information on clinical applications of HDL. Here, specific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.

ISBN: 9789811373831

Standard No.: 10.1007/978-981-13-7383-1doiSubjects--Topical Terms:

583443
Molecular biology.

LC Class. No.: QH506

Dewey Class. No.: 611.01816

High-Density Lipoproteins as Biomarkers and Therapeutic Tools = Volume 2. Improvement and Enhancement of HDL and Clinical Applications /
LDR:03991nam a22004095i 4500 001 1010637
003 DE-He213
005 20200702082709.0
007 cr nn 008mamaa
008 210106s2019 si | s |||| 0|eng d
020 $a 9789811373831 $9 978-981-13-7383-1
024 7 $a 10.1007/978-981-13-7383-1 $2 doi
035 $a 978-981-13-7383-1
050 4 $a QH506
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 611.01816 $2 23
100 1 $a Cho, Kyung-Hyun. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1226693
245 1 0 $a High-Density Lipoproteins as Biomarkers and Therapeutic Tools $h [electronic resource] : $b Volume 2. Improvement and Enhancement of HDL and Clinical Applications / $c by Kyung-Hyun Cho.
250 $a 1st ed. 2019.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a XVI, 268 p. 174 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Chapter 1. Improvement of HDL -- 1-1.Clinical application of HDL: Overview -- 1-2.Regression effect of V156K-apoA-I -- 1-3.Anti-diabetic effect of V156K-apoA-I -- 1-4.Vitamin C and HDL -- 1-5.Growth hormone-1 in HDL -- 1-6.Growth hormone-2 in HDL -- 1-7.Omega-3 and HDL -- Chapter 2. HDL as therapeutic tools -- 2-1.Delivery vehicle for therapeutics : Overview -- 2-2.Gene delivery: adenovirus and V156K-apoA-I -- 2-3.Solubilization of rapamycin and delivery -- 2-4.Solubilization of minoxidil and delivery -- Chapter 3. Enhancement of HDL by policosanol: anti-aging and longevity -- 3-1.Policosanol and HDL functionality -- 3-2.Policosanol and raising HDL in zebrafish -- 3-3.Policosanol and CETP inhibition: human trial 8 weeks -- 3-4.Policosanol and blood pressure lowering: human trial 8 weeks -- 3-5.Policosanol blood pressure lowering human trial for 24 weeks -- 3-6.Policosanol and improvement of aortic stiffness -- 3-7.Policosanol and blood pressure lowering in rat model -- 3-8.Twelve week consumption of policosanol and lowering blood pressure -- 3-9.Publication analysis of policosanol-related studies -- 3-10.Athero-protective effects of policosanol and sugar cane wax acid -- 3-11.Cuban sugarcane wax acids and policosanol improved serum lipid profiles -- Summary and perspectives -- Epilogue.
520 $a This book is the second of two volumes that offer a comprehensive, up-to-date account of current knowledge regarding high-density lipoprotein (HDL), the changes that occur in HDL under different conditions, the clinical applications of HDL, and means of enhancing HDL functionality. In this volume, the focus is on the improvement of HDL, enhancement of its functionality, and the use of HDL for therapeutic purposes. In the first section, up-to-date information is provided on such topics as the tumor regression-promoting and antidiabetic activities of reconstituted HDL containing V156K apolipoprotein A-I, the enhancement of HDL effects by high doses of vitamin C, the benefits derived from incorporation of growth hormones 1 and 2 into rHDL, and the biological functions of omega-3 linolenic acid in rHDL. The enhancement of HDL functionality by policosanol and the resultant benefits are thoroughly examined in a separate section. Readers will also find the latest information on clinical applications of HDL. Here, specific topics include the enhancement of adenoviral gene delivery and the delivery of rapamycin. In documenting the latest knowledge in this field, this volume will be of interest to both researchers and clinicians.
650 0 $a Molecular biology. $3 583443
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Biomedical engineering. $3 588770
650 0 $a Diabetes. $3 582755
650 1 4 $a Molecular Medicine. $3 668353
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Biomedical Engineering/Biotechnology. $3 1068811
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789811373824
776 0 8 $i Printed edition: $z 9789811373848
776 0 8 $i Printed edition: $z 9789811373855
856 4 0 $u https://doi.org/10.1007/978-981-13-7383-1
912 $a ZDB-2-SBL
912 $a ZDB-2-SXB
950 $a Biomedical and Life Sciences (SpringerNature-11642)
950 $a Biomedical and Life Sciences (R0) (SpringerNature-43708)